| Literature DB >> 27082113 |
Wahida Kihal-Talantikite1, Cécile Vigneau2,3, Séverine Deguen1, Muriel Siebert2, Cécile Couchoud4, Sahar Bayat5.
Abstract
BACKGROUND: Public and scientific concerns about the social gradient of end-stage renal disease and access to renal replacement therapies are increasing. This study investigated the influence of social inequalities on the (i) access to renal transplant waiting list, (ii) access to renal transplantation and (iii) patients' survival.Entities:
Mesh:
Year: 2016 PMID: 27082113 PMCID: PMC4833352 DOI: 10.1371/journal.pone.0153431
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Patients’ characteristics at first dialysis and their association with access to the waiting list (univariate and multivariate Cox analyses).
| Patients’ characteristics | Number (%) | Univariate analysis | Multivariate analysis | ||
|---|---|---|---|---|---|
| 2006 | HR (95%CI) | p-value | HR (95%CI) | p-value | |
| 18–39 | 122 (6.1) | 54.52 [36.7–81.1] | <0.001 | 29.81 [18.1–49.1] | <0.001 |
| 40–59 | 425 (21.2) | 38.10 [24.4–54.9] | <0.001 | 23.50 [15.2–36.4] | <0.001 |
| 60–69 | 334 (16.6) | 12.15 [8.2–18.0] | <0.001 | 11.00 [7.01–17.2] | <0.001 |
| ≥70 | 1125 (56.1) | 1 | 1 | ||
| Men | 1216 (60.6) | 1.06 [0.9–1.2] | 0.49 | 1.01 [0.8–1.2] | 0.9 |
| Women | 790 (39.4) | 1 | 1 | ||
| Yes | 264 (14.3) | 8.38[7.0–10.2] | <0.001 | 1.61 [1.3–2.0] | <0.001 |
| No | 1587 (85.7) | 1 | 1 | ||
| <20 | 262 (14) | 0.98 [0.7–1.3] | 0.87 | - | |
| [20–25[ | 783 (41.8) | 1 | - | ||
| [25–30 [ | 537 (28.7) | 0.85 [0.7–1.1] | 0.14 | - | |
| [30–35 [ | 212 (11.3) | 1.02 [0.8–1.3] | 0.85 | - | |
| ≥35 | 79 (4.2) | 0.46 [0.3–0.8] | 0.008 | - | |
| <30 | 347 (20.6) | 0.47 [0.3–0.6] | <0.001 | - | |
| ≥30 | 1334 (79.4) | 1 | |||
| <10 | 600 (32.7) | 1.04 [0.8–1.3] | 0.64 | - | |
| [10–12[ | 879 (47.9) | 1 | - | ||
| ≥12 | 356 (19.4) | 1.31 [1.1–1.6] | 0.02 | - | |
| HD | 1756 (87.5) | 0.85 [0.7–1.1] | 0.20 | - | |
| DP | 250 (12.5) | 1 | - | ||
| Yes | 558 (71.4) | 0.67 [0.5–0.8] | <0.001 | 0.59 [0.5–0.8] | <0.001 |
| No | 1393(28.6) | 1 | 1 | ||
| Private | 791(39.4) | 2.16 [1.8–2.6] | <0.001 | 1.4 1[1.1–1.7] | 0.001 |
| Public, non-university | 943(47.0) | 1 | 1 | ||
| Public, university | 272 (13.6) | 0.52 [0.4–0.8] | 0.001 | 0.64 [0.4–1.0] | 0.06 |
| APKD | 76 (3.8) | 1 | 1 | ||
| Hypertensive & vascular | 481 (24.0) | 0.14 [0.1–0.2] | <0.001 | 0.72 [0.5–1.0] | 0.07 |
| Other & unknown | 786 (39.2) | 0.26 [0.2–0.3] | <0.001 | 0.62 [0.5–0.8] | <0.001 |
| Diabetes | 187 (9.3) | 0.25 [0.2–0.4] | <0.001 | 0.67 [0.4–0.98] | 0.04 |
| Glomerulonephritis | 267 (13.3) | 0.64 [0.5–0.8] | 0.001 | 0.85 [0.6–1.1] | 0.28 |
| Pyelonephritis | 108 (5.4) | 0.59 [0.4–0.8] | 0.003 | 0.77 [0.5–1.1] | 0.19 |
| Yes | 1058 (54.5) | 0.20 [0.2–0.3] | 0.001 | 0.52 [0.4–0.7] | <0.001 |
| No | 883 (45.5) | 1 | 1 | ||
| Yes | 239 (87.5) | 0.38 [0.3–0.6] | <0.001 | - | |
| No | 1668(12.5) | 1 | - | ||
| Yes | 217 (11.4) | 0.18 [0.1–0.3] | <0.001 | 0.28 [0.2–0.5] | <0.001 |
| No | 1689 (88.6 | 1 | 1 | ||
| Yes | 505 (26.0) | 0.49 [0.4–0.6] | <0.001 | - | |
| No | 1437 (74.0) | 1 | - | ||
| Yes | 335 (17.6) | 0.18 [0.1–0.3] | <0.001 | 0.48 [0.3–0.8] | 0.002 |
| No | 1566 (82.4) | 1 | 1 | ||
| Yes | 1 832 (96.3) | 0.21 [0.1–0.5] | 0.001 | 0.23 [0.1–0.6] | <0.001 |
| No | 70 (3.7) | 1 | 1 | ||
| Low | 75(18.7) | 1.40 [1.1–1.7] | 0.002 | 1.04 [0.8–1.3] | >0.5 |
| Moderate | 628(31.3) | 1.06 [0.9–1.3] | 0.53 | 1.14 [0.9–1.4] | 0.7 |
| High | 1003(50.0) | 1 | 1 | ||
| Rural | 946 (47.2) | 1 | - | ||
| Urban | 1060 (52.8) | 0.86 [0.7–1.0] | 0.09 | - | |
† Body Mass Index
‡ polycystic kidney disease
HD: hemodialysis; PD: peritoneal dialysis
Association between patients’ characteristics and access to renal transplantation after placement on the waiting list (univariate and multivariate Cox analyses).
| Patients’ characteristics | Number (%) | Univariate analysis | Multivariate analysis | ||
|---|---|---|---|---|---|
| 546 | HR (95%CI) | p-value | HR (95%CI) | p-value | |
| 18–39 | 104 (19.0) | 1 | 1 | ||
| 40–59 | 302 (55.3) | 1.00 [0.8–1.3] | 0.93 | 0.86 [0.7–1.1] | 0.16 |
| 60–69 | 108 (19.8) | 1.04[0.8–1.4] | 0.74 | 0.89 [0.7–1.2] | 0.20 |
| ≥70 | 32 (5.9) | 1.61[1.1–2.4] | 0.02 | 1.72 [1.1–2.6] | 0.01 |
| Men | 336 (61.5) | 1.01 [0.8–1.2] | 0.90 | 0.95 [0.8–1.2] | 0.71 |
| Women | 210 (38.5) | 1 | 1 | ||
| No | 281 (56.1) | 1 | |||
| Yes | 220 (43.9) | 1.12 [0.9–1.3] | 0.23 | ||
| O | 258 (47.3) | 1 | 1 | ||
| A | 207 (37.9) | 1.95 [1.6–2.4] | <0.001 | 2.17 [1.8–2.8] | <0.001 |
| B | 22 (4.0) | 0.69 [0.5-.0.9] | 0.02 | 0.70 [0.5–0.9] | 0.045 |
| AB | 59 (10.8) | 2.08 [1.3–3.3] | 0.002 | 1.89 [1.1–3.13] | 0.047 |
| %<85 | 525 (96.1) | 1 | 1 | ||
| ≥85 | 21 (3.9) | 0.63 [0.4–1.0] | 0.05 | 0.57 [0.4–0.93] | 0.027 |
| <20 | 73 (13.9) | 0.83 [0.6–1.1] | 0.2 | - | |
| [20–25[ | 232 (44.1) | 1 | - | ||
| [25–30 [ | 141 (26.8) | 0.94 [0.7–1.2] | 0.61 | - | |
| [30–35 [ | 67(12.7) | 0.78 [0.6–1.1] | 0.11 | - | |
| ≥35 | 13 (2.5) | 0.93 [0.5–1.7] | 0.81 | - | |
| <30 | 52 (11.0) | 0.76 [0.5–1.1] | 0.09 | - | |
| ≥30 | 420 (89) | 1 | - | ||
| <10 | 163 (31.8) | 1.01 [0.8–1.3] | 0.85 | ||
| [10–12[ | 232 (45.2) | 1 | |||
| ≥12 | 118 (23) | 0.93 [0.7–1.2] | 0.58 | ||
| HD | 473 (86.6) | 0.88 [0.7–1.2] | 0.37 | ||
| DP | 73 (13.4) | 1 | |||
| Private | 318 (58.2) | 1.17 [1.0–1.4] | 0.09 | - | |
| Public, non-university | 198 (36.3) | 1 | - | ||
| Public, university | 30 (5.5) | 1.33 [0.9–2.1] | 0.19 | - | |
| Yes | 115 (21.1) | 0.95 [0.8–1.2] | 0.67 | ||
| No | 423 (77.5) | 1 | |||
| APKD | 110 (20.2) | 1 | - | ||
| Hypertensive & vascular | 61 (11.2) | 1.03 [0.7–1.4] | 0.83 | - | |
| Other &unknown | 164 (30.0) | 0.71 [0.6–0.99] | 0.04 | - | |
| Diabetes | 41 (7.5) | 0.65 [0.4–0.98] | 0.04 | - | |
| Glomerulonephritis | 124 (22.7) | 0.91 [0.7–1.2] | 0.51 | - | |
| Pyelonephritis | 46 (8.4) | 0.98 [0.7–1.4] | 0.92 | - | |
| Yes | 114 (21.6) | 0.84 [0.7–1.1] | 0.15 | 0.74 [0.6–0.9] | 0.017 |
| No | 414 (78.4) | 1 | 1 | ||
| Yes | 28 (5.3) | 0.67 [0.43–1.0] | 0.07 | - | |
| No | 495(94.6) | 1 | - | ||
| Yes | 13 (2.5) | 0.46 [0.2–0.97] | 0.04 | - | |
| No | 504 (97.5) | 1 | - | ||
| Yes | 86 (16.3) | 0.70 [0.5–0.9] | 0.01 | - | |
| No | 443 (83.7) | 1 | |||
| Yes | 19 (3.6) | 0.58 [0.3–1.0] | 0.07 | - | |
| No | 506 (96.4) | 1 | - | ||
| Yes | 5 (1.0) | 0.72 [0.2–2.3] | 0.57 | ||
| No | 512 (99.0) | 1 | |||
| Low | 129 (23.6) | 0.88 [0.7–1.1] | 0.29 | 0.86 [0.7–1.1] | 0.26 |
| Moderate | 165 (30.2) | 0.99 [0.8–1.2] | 0.95 | 1.03 [0.8–1.3] | 0.90 |
| High | 252 (46.2) | 1 | 1 | ||
| Rural | 277(50.7) | 0.97 [0.8–1.2] | 0.76 | ||
| Urban | 269 (49.3) | 1 | |||
* Body Mass Index
** Polycystic kidney disease
HD: hemodialysis; PD: peritoneal dialysis
Association between patients’ characteristics at first dialysis and mortality (univariate and multivariate Cox analyses).
| Patients’ characteristics | Univariate analysis | Multivariate analysis | ||
|---|---|---|---|---|
| HR (95%CI) | p-value | HR (95%CI) | p-value | |
| 18–39 | 0.05 [0.0–0.1] | <0.001 | 0.18 [0.1–0.4] | <0.001 |
| 40–59 | 0.18 [0.1–0.2] | <0.001 | 0.40 [0.3–0.5] | <0.001 |
| 60–69 | 0.42 [0.3–0.5] | <0.001 | 0.47 [0.4–0.6] | <0.001 |
| > = 70 | 1 | 1 | ||
| Men | 1.11 [0.98–1.3] | 0.09 | 1.1 [0.9–1.34] | 0.120 |
| women | 1 | 1 | ||
| Yes | 0.09 [0.06–0.15] | <0.001 | - | - |
| No | 1 | |||
| <20 | 1.27 [1.04–1.6] | 0.01 | 1.43 [1.-1.8] | 0.003 |
| [20–25[ | 1 | 1 | ||
| [25–30 [ | 1.00 [0.8–1.2] | 0.92 | 0.90 [0.7–1.1] | 0.30 |
| [30–35 [ | 0.99 [0.8–1.2] | 0.96 | 0.87 [0.7–1.1] | 0.33 |
| ≥35 | 0.82 [0.6–1.0] | 0.33 | 0.63 [0.4–1.04] | 0.06 |
| <30 | 1.80 [1.5–2.1] | <0.001 | 1.3 [1.1–1.6] | 0.003 |
| ≥30 | 1 | 1 | ||
| <10 | 1.05 [0.9–1.2] | 0.48 | - | |
| [10–12[ | 1 | - | ||
| ≥12 | 0.83 [0.7–1.0] | 0.06 | - | |
| HD | 0.82 [0.7–0.99] | 0.05 | 0.77 [0.6–0.96] | 0.026 |
| DP | 1 | 1 | ||
| Yes | 1.31 [1.1–1.5] | <0.001 | - | - |
| No | 1 | - | ||
| Yes | 0.08 [0.05–0.1] | <0.001 | 0.25 [0.2–0.4] | <0.001 |
| No | 1 | 1 | ||
| APKD | 1 | 1 | ||
| Hypertensive & vascular | 5.38 [3.6–8.0] | <0.001 | 2.50 [1.5–4.17] | <0.001 |
| Other & unknown | 4.44 [3.0–6.6] | <0.001 | 2.70 [1.6–4.5] | <0.001 |
| Diabetes | 4.32 [2.8–6.6] | <0.001 | 2.64 [1.5–4.6] | <0.001 |
| Glomerulonephritis | 2.16 [1.4–3.3] | <0.001 | 1.72 [0.99–2.99] | 0.053 |
| Pyelonephritis | 2.45 [1.5–4.0] | <0.001 | 2.32 [1.3–4.28] | 0.007 |
| Private | 0.64 [0.6–0.7] | <0.001 | - | - |
| Public, non-university | 1 | - | - | |
| Public university | 1.49 [1.2–1.8] | <0.001 | - | - |
| Yes | 3.40 [2.9–3.9] | <0.001 | 1.83 [1.5–2.2] | <0.001 |
| No | 1 | 1 | ||
| Yes | 1.76 [1.5–2.1] | <0.001 | 1.40 [1.1–1.7] | 0.002 |
| No | 1 | 1 | ||
| Yes | 2.33[1.9–2.8] | <0.001 | 1.51 [1.2–1.89] | <0.001 |
| No | 1 | 1 | ||
| Yes | 1.44[1.2–1.7] | <0.001 | - | |
| No | 1 | - | ||
| Yes | 2.94 [2.5–3.4] | <0.001 | 1.8 [1.5–2.2] | <0.001 |
| No | 1 | 1 | ||
| Yes | 1.64 [1.2–2.2] | 0.001 | - | |
| No | 1 | - | ||
| Low | 0.82 [0.7–0.98] | 0.03 | 0.98 [0.8–1.24] | 0.9 |
| Moderate | 1.02[0.9–1.2] | 0.73 | 1.13 [0.95–1.35] | 0.13 |
| High | 1 | 1 | ||
| Urban | 1.06[0.9–1.2] | 0.35 | ||
| Rural | 1 | |||
* Body Mass Index
** Polycystic kidney disease
HD: hemodialysis; PD: peritoneal dialysis